NAVJOT BAL: Open Payments
NPI 1205461613 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 19 payments from 9 companies in 2025. Trend: 2023 $678 · 2024 $1,343 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $146 |
| Amgen Inc. | 5 | $83 |
| Novo Nordisk Inc | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Lilly USA, LLC | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Nalu Medical, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: FREESTYLE LIBRE 3, OTEZLA, Ozempic, FARXIGA, JARDIANCE, SHINGRIX, VERQUVO, MOUNJARO.
Industry payments across CA — which companies pay providers there.
